[Rapid cochlea lesion induced by co-administration of kanamycin and furosemide in mouse]

Hao Xiong1, Han-qi Chu, Xiao-wen Huang

  • 1Department of Otorhinolaryngology Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Abstract

Insights

This study demonstrates that co-administering kanamycin and furosemide in mice causes rapid and extensive outer hair cell loss, leading to sensorineural hearing loss. This establishes a reliable model for studying cochlear pathology.

Area of Science:

  • Ototoxicity research
  • Auditory neuroscience
  • Drug-induced hearing loss

Context:

  • Kanamycin and furosemide are commonly used drugs with known ototoxic potential.
  • Understanding the mechanisms of drug-induced hearing loss is crucial for developing protective strategies.
  • Establishing reliable animal models is essential for preclinical research.

Purpose:

  • To investigate the ototoxicity of co-administering kanamycin and furosemide in mice.
  • To establish a reliable animal model for inducing sensorineural hearing loss.
  • To characterize the resulting cochlear pathology and hair cell degeneration.

Summary:

  • CBA/J mice received kanamycin and furosemide, exhibiting significant auditory brainstem response (ABR) threshold shifts within 12 hours.
  • Pathological examination revealed rapid and extensive outer hair cell loss, primarily through apoptosis, with delayed and milder inner hair cell damage.
  • Scanning electron microscopy showed necrotic outer hair cells, supporting cell changes, and progressive strial vascularis thinning.

Impact:

  • This protocol provides a robust in vivo model for extensive hair cell elimination.
  • It facilitates the study of cochlear pathology in various transgenic or mutant mouse strains.
  • The findings contribute to understanding the mechanisms of ototoxicity and developing therapeutic interventions.